Skip to main content

Main menu

  • Home
  • COVID-19
    • Articles & podcasts
    • Blog posts
    • Collection
    • News
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
  • Authors
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
  • CMA Members
    • Overview for members
    • Earn CPD Credits
    • Print copies of CMAJ
    • Career Ad Discount
  • Subscribers
    • General information
    • View prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2021
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • COVID-19
    • Articles & podcasts
    • Blog posts
    • Collection
    • News
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
  • Authors
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
  • CMA Members
    • Overview for members
    • Earn CPD Credits
    • Print copies of CMAJ
    • Career Ad Discount
  • Subscribers
    • General information
    • View prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2021
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Pinterest
  • Follow CMAJ on Youtube
  • Follow CMAJ on Instagram
Letters

Summary Basis of Decision in context

Joel Lexchin and Barbara Mintzes
CMAJ June 21, 2005 172 (13) 1664-1665; DOI: https://doi.org/10.1503/cmaj.1050055
Joel Lexchin
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Barbara Mintzes
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Responses
  • Metrics
  • PDF
Loading
  • © 2005 CMA Media Inc. or its licensors

Diane Gorman maintains that Canadian federal statutes prevent Health Canada from releasing clinical information about safety and efficacy without the consent of the company submitting the data. In doing so, she ignores a section of the Access to Information Act that allows the release of such information if it “would be in the public interest as it relates to public health.”1 To our knowledge, Health Canada has never chosen to use this clause to disclose information.

Health Canada's Science Advisory Board examined whether the North American Free Trade Agreement created a barrier to disclosure of premarket clinical trial data and concluded that “Measures to require transparency for the protection of the public are not a violation of this treaty obligation.”2

Ms. Gorman points out that the FDA stopped posting Summary Basis of Approval documents in 1994, but that was because of the workload involved, not because of the North American Free Trade Agreement. The redacted review information still contains detailed reports of methods and results of the clinical trials that the companies performed. As we pointed out in our commentary,3 that information is not available in the SBD.

Finally, Ms. Gorman says that Health Canada's consultations show that consumer associations and health care providers find the SBD a major step forward. She fails to mention the statement issued by those attending the Health Canada SBD consultation, who endorsed the goal of transparency but stated firmly that “the model for a Summary Basis of Decision put forward at this consultation does not meet these common goals.” Groups signing the statement included the Canadian Organization for Rare Diseases, Doctors for Research Integrity, the Hospital Employees Union, the Society for Diabetic Rights, Women and Health Protection, PharmaWatch and the BC Persons With AIDS Society.

References

  1. 1.↵
    Access to Information Act, R.S.C. 1985, c. A-1, s. 20 (6).
  2. 2.↵
    Science Advisory Board Committee on the Drug Review Process. Appendix F: Notes on Canadian law and the drug review process. In: Report to Health Canada. Ottawa: The Committee; 2000.
  3. 3.↵
    Lexchin J, Mintzes B. Transparency in drug regulation: Mirage or oasis? [editorial]. CMAJ 2004;171(11):1363-5.
    OpenUrlFREE Full Text
PreviousNext
Back to top

In this issue

Canadian Medical Association Journal: 172 (13)
CMAJ
Vol. 172, Issue 13
21 Jun 2005
  • Table of Contents
  • Index by author

Article tools

Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Summary Basis of Decision in context
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Summary Basis of Decision in context
Joel Lexchin, Barbara Mintzes
CMAJ Jun 2005, 172 (13) 1664-1665; DOI: 10.1503/cmaj.1050055

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
Summary Basis of Decision in context
Joel Lexchin, Barbara Mintzes
CMAJ Jun 2005, 172 (13) 1664-1665; DOI: 10.1503/cmaj.1050055
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • References
  • Responses
  • Metrics
  • PDF

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Building research infrastructure across a health service
  • A safe return to sport and the right to play during COVID-19
  • Simple-language tool to guide patients in recovery after prolonged treatment in the intensive care unit
Show more Letters

Similar Articles

Collections

  • Topics
    • Drugs: urogenital
    • Drug regulation

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions

Copyright 2021, Joule Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

To receive any of the resources on this site in an accessible format, please contact us at cmajgroup@cmaj.ca.

Powered by HighWire